When clinical indicators of AD such as age, sex, BMI, years of education, and APOE ε4 carrier status were added, the AUC value for predicting AD stage increased to a certain extent, showing a stronger predictive value for the AD spectrum (AUC > 0.9). This evidence concerns the gene APOE and Alzheimer disease.